PACIRA BIOSCIENCES, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • February 29th, 2024 • Pacira BioSciences, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement made and entered into this _______ day of _________, 20___ (the “Agreement”), by and between Pacira BioSciences, Inc., a Delaware corporation (the “Company,” which term shall include, where appropriate, any Entity (as hereinafter defined) controlled directly or indirectly by the Company) and _________________ (the “Indemnitee”):
PACIRA BIOSCIENCES, INC. Nonstatutory Stock Option Agreement Granted Under Amended and Restated 2014 Inducement PlanStock Option Agreement • February 29th, 2024 • Pacira BioSciences, Inc. • Pharmaceutical preparations
AMENDMENT AGREEMENTAmendment Agreement • February 29th, 2024 • Pacira BioSciences, Inc. • Pharmaceutical preparations
This Amendment Agreement (this “Amendment Agreement”) is between Flexion Therapeutics, Inc., having its principal office at 10 Mall Road, Burlington MA, USA (“Flexion”) and Patheon UK Limited, having a principal place of business at Kingfisher Drive, Covingham, Swindon, Wiltshire SN35BZ, United Kingdom (“Patheon”) (collectively, “Parties”; individually, “Party”). This Amendment Agreement is dated 8 May 2019 (the “Amendment Effective Date”).
AMENDMENT AGREEMENTAmendment Agreement • February 29th, 2024 • Pacira BioSciences, Inc. • Pharmaceutical preparations
This Amendment Agreement (this “Amendment Agreement”) is between Pacira Pharmaceuticals, Inc., having its office at 5 Sylvan Way, Suite 300, Parsippany, NJ 07054, USA (“Pacira”) and Patheon UK Limited, having a principal place of business at Kingfisher Drive, Covingham, Swindon, Wiltshire SN35BZ, United Kingdom (“Patheon”) (collectively, “Parties”; individually, “Party”). This Amendment Agreement is dated 1 December 2023 (the “Amendment Effective Date”).
COMMERCIAL OUTSOURCING SERVICES AGREEMENTCommercial Outsourcing Services Agreement • February 29th, 2024 • Pacira BioSciences, Inc. • Pharmaceutical preparations • Delaware
This Commercial Outsourcing Services Agreement (this “Agreement”) is entered into as of February 26, 2024 (the “Effective Date”) by Integrated Commercialization Solutions, LLC (“ICS”) and Pacira Pharmaceuticals, Inc. (the “Company”).
AMENDMENT AGREEMENTAmendment Agreement • February 29th, 2024 • Pacira BioSciences, Inc. • Pharmaceutical preparations
This Amendment Agreement (this “Amendment Agreement”) is between Flexion Therapeutics, Inc., having its principal office at 10 Mall Road, Burlington MA, USA (“Flexion”) and Patheon UK Limited, having a principal place of business at Kingfisher Drive, Covingham, Swindon, Wiltshire SN35BZ, United Kingdom (“Patheon”) (collectively, “Parties”; individually, “Party”). This Amendment Agreement is dated 17 June 2019 (the “Amendment Effective Date”).
